RUBY Insider Trading - Rubius Therapeutics, Inc.

Saham Orang Dalam

12,156,127 shares

Skor Sentimen Orang Dalam

Skor Sentimen Orang Dalam mendapati syarikat dibeli oleh orang dalam korporat.

Ia adalah hasil daripada model kuantitatif berbilang faktor yang canggih yang mengenal pasti syarikat dengan tahap pengumpulan orang dalam yang paling tinggi. Model pemarkahan menggunakan gabungan bilangan bersih orang dalam yang membeli 90 hari sebelumnya, jumlah saham yang dibeli sebagai peratusan saham beredar, dan jumlah saham yang dimiliki oleh orang dalam. Nombor ini berjulat dari 0 hingga 100, dengan nombor yang lebih tinggi menunjukkan tahap pengumpulan yang lebih tinggi kepada rakannya, dan 50 adalah purata.

Kekerapan Kemas Kini: Harian

Lihat Pilihan Teratas Orang Dalam, yang menyediakan senarai syarikat dengan pengumpulan orang dalam tertinggi.

Lihat Saham Kedudukan Tertinggi

Skor Sentimen Pegawai

Skor Sentimen Pegawai mendapati syarikat dibeli oleh Pegawai Korporat.

Mengikut definisi Pegawai Korporat ialah Orang Dalam Korporat, tetapi tidak seperti beberapa Orang Dalam yang lain (10% Pemegang Saham dan Ahli Lembaga), Pegawai bekerja untuk syarikat tersebut setiap hari, dan mereka menggunakan wang mereka sendiri semasa berdagang . (10% Pemegang Saham dan Ahli Lembaga Pengarah selalunya pengurus dana yang menguruskan wang orang lain.) Oleh itu, dagangan orang dalam yang dibuat oleh Pegawai adalah lebih penting dan harus dilayan dengan sewajarnya.

Seperti Skor Sentimen Orang Dalam, Skor Sentimen Pegawai adalah hasil daripada model kuantitatif berbilang faktor yang canggih yang mengenal pasti syarikat yang mempunyai tahap pengumpulan pegawai tertinggi.

Kekerapan Kemas Kini: Harian

Lihat Pilihan Teratas Orang Dalam, yang menyediakan senarai syarikat yang mempunyai sentimen orang dalam tertinggi.

Lihat Saham Kedudukan Tertinggi

Metrik Orang Dalam Utama

Kad ini menunjukkan bagaimana kedudukan syarikat mengikut pelbagai metrik orang dalam. Kedudukan persentil menunjukkan cara syarikat ini dibandingkan dengan syarikat lain di pasaran AS. Kedudukan yang lebih tinggi menunjukkan keadaan yang lebih baik.

Sebagai contoh, adalah diterima umum bahawa pembelian orang dalam ialah penunjuk positif, jadi syarikat yang mempunyai lebih banyak pembelian orang dalam akan mendapat kedudukan lebih tinggi daripada syarikat yang kurang pembelian orang dalam (atau malah jualan orang dalam).

Bilangan Bersih Pembelian Orang Dalam (Kedudukan)

N/A

Bilangan Bersih Pembelian Orang Dalam ialah jumlah bilangan orang dalam yang membeli tolak jumlah orang dalam yang menjual dalam tempoh 90 hari terakhir. Kedudukan persentil ditunjukkan di sini (julat dari 0 hingga 100%).

Peratusan Saham Beredar yang Dibeli oleh Orang Dalam (Kedudukan)

N/A

Peratusan Saham Beredar yang Dibeli oleh Orang Dalam ialah jumlah bilangan saham yang dibeli oleh orang dalam tolak jumlah bilangan saham yang dijual oleh orang dalam dalam tempoh 90 hari terakhir, dibahagikan dengan jumlah saham beredar dan didarab dengan 100.

Carta Dagangan Dalaman

Rubius Therapeutics, Inc. dagangan dalaman ditunjukkan dalam carta berikut. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Secara umumnya adalah menyalahi undang-undang bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat material dan bukan awam. Ini tidak bermakna haram untuk mereka membuat sebarang perdagangan dalam syarikat mereka sendiri. Walau bagaimanapun, mereka mesti melaporkan semua dagangan kepada SEC melalui Borang 4.

Senarai Orang Dalam dan Metrik Keberuntungan

Jadual ini menunjukkan senarai orang dalam yang diketahui dan dijana secara automatik daripada pemfailan yang didedahkan kepada SEC. Sebagai tambahan kepada nama, gelaran terkini dan pengarah, pegawai, atau 10% jawatan pemilik, kami menyediakan pegangan yang didedahkan terkini. Selain itu, apabila boleh, kami menyediakan sejarah prestasi perdagangan untuk orang dalam. Sejarah prestasi perdagangan ialah purata wajaran prestasi transaksi pembelian pasaran terbuka sebenar yang dibuat oleh orang dalam. Untuk mendapatkan maklumat lanjut tentang cara ini dikira, tonton webinar YouTube ini.

See our leaderboard of most profitable insider traders.

Orang dalam	Purata Keuntungan (%)	Saham Dimiliki	Berpecah Dilaraskan

Report errors via our new Insider Auditing Tool

Rekod Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam RUBY / Rubius Therapeutics, Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan	Orang dalam	Dilaporkan Saham	Dilaporkan harga	Dilaraskan Saham	Dilaraskan harga	Asas Kos	Hari ke Maks	Harga pada Maks	Maks Keuntungan ($)	Pulangan Maks (%)
2022-04-21	Epstein David R	30,000	1.4443	30,000	1.4443	43,329	4	1.8700	12,771	29.47
2021-03-19	Flagship Ventures Fund IV General Partner LLC	70,000	29.0000	70,000	29.0000	2,030,000
2021-03-19	Flagship Ventures Fund IV General Partner LLC	70,000	29.0000	70,000	29.0000	2,030,000
2021-03-19	Flagship Ventures Fund IV General Partner LLC	70,000	29.0000	70,000	29.0000	2,030,000
2020-04-22	Coughlin Christina M.	19,000	5.5165	19,000	5.5165	104,814
2020-04-14	CAGNONI PABLO J	21,000	4.6997	21,000	4.6997	98,694
2020-03-17	Epstein David R	5,000	3.7600	5,000	3.7600	18,800
2020-03-13	Epstein David R	5,000	4.0000	5,000	4.0000	20,000
2020-03-13	Epstein David R	5,000	3.8200	5,000	3.8200	19,100

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras pecah.

RUBY / Rubius Therapeutics, Inc. Insider Trades

Rekod Jejak Jualan Orang Dalam - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam RUBY / Rubius Therapeutics, Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan	Orang dalam	Dilaporkan Saham	Dilaporkan harga	Dilaraskan Saham	Dilaraskan harga	Asas Kos	Hari ke Min	Harga pada Min	Kerugian Maks Dielakkan ($)	Kerugian Maks Dielakkan (%)
2023-02-24	Appelhans Dannielle	10,385	0.1274	10,385	0.1274	1,323	28	0.0153	-1,164	-87.99
2023-02-01	Appelhans Dannielle	3,878	0.2500	3,878	0.2500	970
2023-02-01	CAGNONI PABLO J	8,448	0.2500	8,448	0.2500	2,112
2023-01-31	Turka Laurence A.	2,593	0.2400	2,593	0.2400	622
2023-01-31	CAGNONI PABLO J	7,240	0.2410	7,240	0.2410	1,745
2022-08-10	Appelhans Dannielle	5,737	0.8000	5,737	0.8000	4,590
2022-02-01	Keson-Brookes Maiken	2,732	6.5730	2,732	6.5730	17,957
2022-02-01	CAGNONI PABLO J	6,730	6.5730	6,730	6.5730	44,236
2022-02-01	Turka Laurence A.	2,517	6.5730	2,517	6.5730	16,544

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras pecah.

Sejarah Transaksi

Klik ikon pautan untuk melihat sejarah transaksi penuh. Transaksi yang dilaporkan sebagai sebahagian daripada pelan dagangan automatik 10b5-1 akan mempunyai X dalam lajur bertanda 10b-5.

Fail Tarikh	Dagangan Tarikh	Borang	Orang dalam	Simbol Saham	Nama Sekuriti	Kod	Langsung	Harga Pelaksanaan	Harga Unit	Unit Berubah	Nilai Berubah (1K)	Baki Opsyen	Baki Saham
2023-02-27	2023-02-24	4	Appelhans Dannielle	RUBY	Common Stock	S - Sale	D		0.1274	-10,385	-1		0
2023-02-01	2023-02-01	4	CAGNONI PABLO J	RUBY	Common Stock	S - Sale	D		0.2500	-8,448	-2		66,082
2023-02-01	2023-02-01	4	Appelhans Dannielle	RUBY	Common Stock	S - Sale	D		0.2500	-3,878	-1		10,385
2023-02-01	2023-01-31	4	Appelhans Dannielle	RUBY	Common Stock	M - Exercise	D			7,500			14,263
2023-01-31	2023-01-31	4	CAGNONI PABLO J	RUBY	Common Stock	S - Sale	D		0.2410	-7,240	-2		74,530
2023-01-31	2023-01-31	4	CAGNONI PABLO J	RUBY	Common Stock	M - Exercise	D			25,000			81,770
2023-01-31	2023-01-29	4	CAGNONI PABLO J	RUBY	Common Stock	M - Exercise	D			21,250			56,770
2023-01-31	2023-01-31	4	Turka Laurence A.	RUBY	Common Stock	S - Sale	D		0.2400	-2,593	-1		18,391
2023-01-31	2023-01-31	4	Turka Laurence A.	RUBY	Common Stock	M - Exercise	D			8,625			20,984
2023-01-31	2023-01-29	4	Turka Laurence A.	RUBY	Common Stock	M - Exercise	D			7,438			12,359
2022-08-12	2022-08-10	4	Appelhans Dannielle	RUBY	Common Stock	S - Sale	D		0.8000	-5,737	-5		6,763
2022-08-12	2022-08-09	4	Appelhans Dannielle	RUBY	Common Stock	M - Exercise	D			12,500			12,500
2022-05-13	2022-05-12	4	Holles Natalie C.	RUBY	Stock Option (Right to Buy)	A - Award	D	1.24		25,000		25,000
2022-05-13	2022-05-12	4	Prener Anne	RUBY	Stock Option (Right to Buy)	A - Award	D	1.24		25,000		25,000
2022-05-13	2022-05-12	4	Symonds Jonathan	RUBY	Stock Option (Right to Buy)	A - Award	D	1.24		25,000		25,000
2022-05-13	2022-05-12	4	AFEYAN NOUBAR	RUBY	Stock Option (Right to Buy)	A - Award	D	1.24		25,000		25,000
2022-05-13	2022-05-12	4	Cuss Francis M	RUBY	Stock Option (Right to Buy)	A - Award	D	1.24		25,000		25,000
2022-05-13	2022-05-12	4	Rosenblatt Michael	RUBY	Stock Option (Right to Buy)	A - Award	D	1.24		25,000		25,000
2022-05-13	2022-05-12	4	Sohn Catherine A.	RUBY	Stock Option (Right to Buy)	A - Award	D	1.24		25,000		25,000
2022-05-13	2022-05-12	4	Epstein David R	RUBY	Stock Option (Right to Buy)	A - Award	D	1.24		499,762		499,762
2022-04-22	2022-04-21	4	Epstein David R	RUBY	Common Stock	P - Purchase	D		1.4443	30,000	43		4,720,012
2022-02-14	2021-06-16	5	CAGNONI PABLO J	RUBY	Common Stock	G - Gift	D			-2,200			29,320
2022-02-14	2021-04-26	5	CAGNONI PABLO J	RUBY	Common Stock	G - Gift	D			-4,000			31,520
2022-02-01	2022-01-31	4	Carmona Jose	RUBY	Restricted Stock Units	A - Award	D			34,500		34,500
2022-02-01	2022-01-31	4	Carmona Jose	RUBY	Stock Option (Right to Buy)	A - Award	D	6.75		143,750		143,750
2022-02-01	2022-02-01	4	CAGNONI PABLO J	RUBY	Common Stock	S - Sale	D		6.5730	-6,730	-44		35,520
2022-02-01	2022-01-31	4	CAGNONI PABLO J	RUBY	Restricted Stock Units	A - Award	D			100,000		100,000
2022-02-01	2022-01-31	4	CAGNONI PABLO J	RUBY	Stock Option (Right to Buy)	A - Award	D	6.75		365,000		365,000
2022-02-01	2022-01-29	4	CAGNONI PABLO J	RUBY	Restricted Stock Units	M - Exercise	D			-21,250		63,750
2022-02-01	2022-01-29	4	CAGNONI PABLO J	RUBY	Common Stock	M - Exercise	D			21,250			42,250
2022-02-01	2022-02-01	4	Keson-Brookes Maiken	RUBY	Common Stock	S - Sale	D		6.5730	-2,732	-18		5,343
2022-02-01	2022-01-31	4	Keson-Brookes Maiken	RUBY	Restricted Stock Units	A - Award	D			34,500		34,500
2022-02-01	2022-01-31	4	Keson-Brookes Maiken	RUBY	Stock Option (Right to Buy)	A - Award	D	6.75		143,750		143,750
2022-02-01	2022-01-29	4	Keson-Brookes Maiken	RUBY	Restricted Stock Units	M - Exercise	D			-8,075		24,225
2022-02-01	2022-01-29	4	Keson-Brookes Maiken	RUBY	Common Stock	M - Exercise	D			8,075			8,075
2022-02-01	2022-01-31	4	Appelhans Dannielle	RUBY	Restricted Stock Units	A - Award	D			30,000		30,000
2022-02-01	2022-01-31	4	Appelhans Dannielle	RUBY	Stock Option (Right to Buy)	A - Award	D	6.75		125,000		125,000
2022-02-01	2022-02-01	4	Turka Laurence A.	RUBY	Common Stock	S - Sale	D		6.5730	-2,517	-17		4,921
2022-02-01	2022-01-31	4	Turka Laurence A.	RUBY	Restricted Stock Units	A - Award	D			34,500		34,500
2022-02-01	2022-01-31	4	Turka Laurence A.	RUBY	Stock Option (Right to Buy)	A - Award	D	6.75		143,750		143,750
2022-02-01	2022-01-29	4	Turka Laurence A.	RUBY	Restricted Stock Units	M - Exercise	D			-7,438		22,312
2022-02-01	2022-01-29	4	Turka Laurence A.	RUBY	Common Stock	M - Exercise	D			7,438			7,438
2021-09-01	2021-08-31	4	Appelhans Dannielle	RUBY	Restricted Stock Units	A - Award	D			50,000		50,000
2021-09-01	2021-08-31	4	Appelhans Dannielle	RUBY	Stock Option (Right to Buy)	A - Award	D	21.72		150,000		150,000
2021-05-13	2021-05-12	4	Prener Anne	RUBY	Stock Option (Right to Buy)	A - Award	D	23.25		25,000		25,000
2021-05-13	2021-05-12	4	Cuss Francis M	RUBY	Stock Option (Right to Buy)	A - Award	D	23.25		25,000		25,000
2021-05-13	2021-05-12	4	AFEYAN NOUBAR	RUBY	Stock Option (Right to Buy)	A - Award	D	23.25		25,000		25,000
2021-05-13	2021-05-12	4	Sohn Catherine A.	RUBY	Stock Option (Right to Buy)	A - Award	D	23.25		25,000		25,000
2021-05-13	2021-05-12	4	Rosenblatt Michael	RUBY	Stock Option (Right to Buy)	A - Award	D	23.25		25,000		25,000
2021-05-13	2021-05-12	4	Epstein David R	RUBY	Stock Option (Right to Buy)	A - Award	D	23.25		27,919		27,919
2021-05-13	2021-05-12	4	Holles Natalie C.	RUBY	Stock Option (Right to Buy)	A - Award	D	23.25		25,000		25,000
2021-05-13	2021-05-12	4	Symonds Jonathan	RUBY	Stock Option (Right to Buy)	A - Award	D	23.25		25,000		25,000
2021-03-23	2021-03-19	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	P - Purchase	I		29.0000	70,000	2,030		2,633,703
2021-03-23	2021-03-19	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	P - Purchase	I		29.0000	70,000	2,030		2,633,703
2021-03-23	2021-03-19	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	P - Purchase	I		29.0000	70,000	2,030		15,393,593
2021-03-15	2021-03-15	4	Keson-Brookes Maiken	RUBY	Stock Option (Right to Buy)	M - Exercise	D	7.70		-25,000		225,000
2021-03-15	2021-03-15	4	Keson-Brookes Maiken	RUBY	Common Stock	S - Sale	D		20.2386	-25,000	-506		0
2021-03-15	2021-03-15	4	Keson-Brookes Maiken	RUBY	Common Stock	M - Exercise	D		7.7000	25,000	192		25,000
2021-02-16	2021-02-11	4	Epstein David R	RUBY	Common Stock	S - Sale	D		14.9251	-26,704	-399		4,690,012
2021-02-10	2021-02-10	4	Epstein David R	RUBY	Common Stock	S - Sale	D		14.7927	-7,404	-110		4,716,716
2021-02-10	2021-02-09	4	Epstein David R	RUBY	Common Stock	S - Sale	D		14.8314	-2,100	-31		4,724,120
2021-02-10	2021-02-08	4	Epstein David R	RUBY	Common Stock	S - Sale	D		14.8837	-89,233	-1,328		4,726,220
2021-02-02	2021-01-29	4	CAGNONI PABLO J	RUBY	Restricted Stock Units	A - Award	D			85,000		85,000
2021-02-02	2021-01-29	4	CAGNONI PABLO J	RUBY	Stock Option (Right to Buy)	A - Award	D	11.97		375,000		375,000
2021-02-02	2021-01-29	4	Keson-Brookes Maiken	RUBY	Restricted Stock Units	A - Award	D			32,300		32,300
2021-02-02	2021-01-29	4	Keson-Brookes Maiken	RUBY	Stock Option (Right to Buy)	A - Award	D	11.97		142,500		142,500
2021-02-02	2021-01-29	4	Turka Laurence A.	RUBY	Restricted Stock Units	A - Award	D			29,750		29,750
2021-02-02	2021-01-29	4	Turka Laurence A.	RUBY	Stock Option (Right to Buy)	A - Award	D	11.97		131,250		131,250
2021-02-02	2021-01-29	4	Coughlin Christina M.	RUBY	Restricted Stock Units	A - Award	D			32,300		32,300
2021-02-02	2021-01-29	4	Coughlin Christina M.	RUBY	Stock Option (Right to Buy)	A - Award	D	11.97		142,500		142,500
2020-12-02	2020-11-30	4	Carmona Jose	RUBY	Stock Option (Right to Buy)	A - Award	D	6.27		400,000		400,000
2020-05-26	2020-05-21	4	Holles Natalie C.	RUBY	Stock Option (Right to Buy)	A - Award	D	6.22		25,000		25,000
2020-05-26	2020-05-21	4	Epstein David R	RUBY	Stock Option (Right to Buy)	A - Award	D	6.22		115,771		115,771
2020-05-26	2020-05-21	4	Symonds Jonathan	RUBY	Stock Option (Right to Buy)	A - Award	D	6.22		25,000		25,000
2020-05-26	2020-05-21	4	AFEYAN NOUBAR	RUBY	Stock Option (Right to Buy)	A - Award	D	6.22		25,000		25,000
2020-05-26	2020-05-21	4	Sohn Catherine A.	RUBY	Stock Option (Right to Buy)	A - Award	D	6.22		25,000		25,000
2020-05-26	2020-05-21	4	Rosenblatt Michael	RUBY	Stock Option (Right to Buy)	A - Award	D	6.22		25,000		25,000
2020-05-26	2020-05-21	4	Cuss Francis M	RUBY	Stock Option (Right to Buy)	A - Award	D	6.22		25,000		25,000
2020-05-19	2020-05-15	4	OH ANDREW M.	RUBY	Stock Option (Right to Buy)	M - Exercise	D	4.74		-5,000		755,500
2020-05-19	2020-05-15	4	OH ANDREW M.	RUBY	Common Stock	M - Exercise	D		4.7400	5,000	24		5,000
2020-04-24	2020-04-22	4	Coughlin Christina M.	RUBY	Common Stock	P - Purchase	D		5.5165	19,000	105		19,000
2020-04-15	2020-04-14	4	CAGNONI PABLO J	RUBY	Common Stock	P - Purchase	D		4.6997	21,000	99		21,000
2020-03-19	2020-03-17	4	Epstein David R	RUBY	Common Stock	P - Purchase	D		3.7600	5,000	19		4,815,453
2020-03-17	2020-03-13	4	Epstein David R	RUBY	Common Stock	P - Purchase	D		4.0000	5,000	20		4,810,453
2020-03-17	2020-03-13	4	Epstein David R	RUBY	Common Stock	P - Purchase	D		3.8200	5,000	19		4,805,453
2020-02-03	2020-01-31	4	OH ANDREW M.	RUBY	Stock Option (Right to Buy)	A - Award	D	7.80		165,000		165,000
2020-02-03	2020-01-31	4	Turka Laurence A.	RUBY	Stock Option (Right to Buy)	A - Award	D	7.80		350,000		350,000
2020-02-03	2020-01-31	4	CAGNONI PABLO J	RUBY	Stock Option (Right to Buy)	A - Award	D	7.80		500,000		500,000
2020-02-03	2020-01-31	4	Coughlin Christina M.	RUBY	Stock Option (Right to Buy)	A - Award	D	7.80		375,000		375,000
2020-01-03	2019-12-31	4	Prener Anne	RUBY	Stock Option (Right to Buy)	A - Award	D	9.50		50,000		50,000
2019-12-18	2019-12-16	4	CARPENTER CHRISTOPHER L.	RUBY	Stock Option (Right to Buy)	M - Exercise	D	2.87		-48,000		523,157
2019-12-18	2019-12-16	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	S - Sale	D		13.4771	-48,000	-647		34,843
2019-12-18	2019-12-16	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	M - Exercise	D		2.8700	48,000	138		82,843
2019-12-03	2019-11-29	4	Keson-Brookes Maiken	RUBY	Stock Option (Right to Buy)	A - Award	D	7.70		250,000		250,000
2019-10-17	2019-10-14	4	LANGER ROBERT	RUBY	Stock Option (Right to Buy)	M - Exercise	D	0.15		-7,500		120,000
2019-10-17	2019-10-14	4	LANGER ROBERT	RUBY	Common Stock	S - Sale	D		8.5166	-7,500	-64		0
2019-10-17	2019-10-14	4	LANGER ROBERT	RUBY	Common Stock	M - Exercise	D		0.1500	7,500	1		7,500
2019-09-18	2019-09-17	4	CARPENTER CHRISTOPHER L.	RUBY	Stock Option (Right to Buy)	M - Exercise	D	2.87		-11,877		571,157
2019-09-18	2019-09-17	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	S - Sale	D		10.0454	-11,877	-119		34,843
2019-09-18	2019-09-17	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	M - Exercise	D		2.8700	11,877	34		46,720
2019-09-18	2019-09-16	4	CARPENTER CHRISTOPHER L.	RUBY	Stock Option (Right to Buy)	M - Exercise	D	2.87		-36,123		583,034
2019-09-18	2019-09-16	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	S - Sale	D		10.1292	-36,123	-366		34,843
2019-09-18	2019-09-16	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	M - Exercise	D		2.8700	36,123	104		70,966
2019-07-26	2019-07-24	4	NISSEN TORBEN STRAIGHT	RUBY	Stock Option (Right to Buy)	M - Exercise	D	0.19		-32,146		82,854
2019-07-26	2019-07-24	4	NISSEN TORBEN STRAIGHT	RUBY	Stock Option (Right to Buy)	M - Exercise	D	0.18		-175,000		175,000
2019-07-26	2019-07-24	4	NISSEN TORBEN STRAIGHT	RUBY	Common Stock	M - Exercise	D		0.1900	32,146	6		2,052,450
2019-07-26	2019-07-24	4	NISSEN TORBEN STRAIGHT	RUBY	Common Stock	M - Exercise	D		0.1800	175,000	32		2,020,304
2019-07-17	2019-07-15	4	LANGER ROBERT	RUBY	Stock Option (Right to Buy)	M - Exercise	D	0.15		-7,500		127,500
2019-07-17	2019-07-15	4	LANGER ROBERT	RUBY	Common Stock	S - Sale	D		14.9398	-7,500	-112		0
2019-07-17	2019-07-15	4	LANGER ROBERT	RUBY	Common Stock	M - Exercise	D		0.1500	7,500	1		7,500
2019-06-24	2019-06-20	4	CARPENTER CHRISTOPHER L.	RUBY	Stock Option (Right to Buy)	M - Exercise	D	2.87		-243		619,157
2019-06-24	2019-06-20	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	S - Sale	D		13.9340	-243	-3		34,843
2019-06-24	2019-06-20	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	M - Exercise	D		2.8700	243	1		35,086
2019-06-19	2019-06-19	4	CARPENTER CHRISTOPHER L.	RUBY	Stock Option (Right to Buy)	M - Exercise	D	2.87		-18,399		619,400
2019-06-19	2019-06-19	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	S - Sale	D		13.7979	-18,399	-254		34,843
2019-06-19	2019-06-19	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	M - Exercise	D		2.8700	18,399	53		53,242
2019-06-19	2019-06-18	4	CARPENTER CHRISTOPHER L.	RUBY	Stock Option (Right to Buy)	M - Exercise	D	2.87		-10,858		637,799
2019-06-19	2019-06-18	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	S - Sale	D		14.2713	-10,858	-155		34,843
2019-06-19	2019-06-18	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	M - Exercise	D		2.8700	10,858	31		45,701
2019-06-19	2019-06-17	4	CARPENTER CHRISTOPHER L.	RUBY	Stock Option (Right to Buy)	M - Exercise	D	2.87		-18,500		648,657
2019-06-19	2019-06-17	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	S - Sale	D		14.1010	-18,500	-261		34,843
2019-06-19	2019-06-17	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	M - Exercise	D		2.8700	18,500	53		53,343
2019-05-28	2019-05-23	4	Cuss Francis M	RUBY	Stock Option (Right to Buy)	A - Award	D	16.27		25,000		25,000
2019-05-28	2019-05-23	4	Epstein David R	RUBY	Stock Option (Right to Buy)	A - Award	D	16.27		39,094		39,094
2019-05-28	2019-05-23	4	LANGER ROBERT	RUBY	Stock Option (Right to Buy)	A - Award	D	16.27		25,000		25,000
2019-05-28	2019-05-23	4	Rosenblatt Michael	RUBY	Stock Option (Right to Buy)	A - Award	D	16.27		25,000		25,000
2019-05-28	2019-05-23	4	Sohn Catherine A.	RUBY	Stock Option (Right to Buy)	A - Award	D	16.27		25,000		25,000
2019-05-28	2019-05-23	4	Symonds Jonathan	RUBY	Stock Option (Right to Buy)	A - Award	D	16.27		25,000		25,000
2019-05-28	2019-05-23	4	AFEYAN NOUBAR	RUBY	Stock Option (Right to Buy)	A - Award	D	16.27		25,000		25,000
2019-04-17	2019-04-15	4	LANGER ROBERT	RUBY	Stock Option (Right to Buy)	M - Exercise	D	0.15		-7,500		135,000
2019-04-17	2019-04-15	4	LANGER ROBERT	RUBY	Common Stock	S - Sale	D		17.5732	-7,500	-132		0
2019-04-17	2019-04-15	4	LANGER ROBERT	RUBY	Common Stock	M - Exercise	D		0.1500	7,500	1		7,500
2019-04-10	2019-04-08	4	NISSEN TORBEN STRAIGHT	RUBY	Common Stock	S - Sale	D		20.0000	-2,100	-42		1,845,304
2019-04-05	2019-04-05	4	NISSEN TORBEN STRAIGHT	RUBY	Common Stock	S - Sale	D		20.0000	-12,096	-242		1,847,404
2019-04-05	2019-04-03	4	NISSEN TORBEN STRAIGHT	RUBY	Common Stock	S - Sale	D		20.0000	-500	-10		1,859,500
2019-04-01	2019-03-29	4	Holles Natalie C.	RUBY	Stock Option (Right to Buy)	A - Award	D	18.10		50,000		50,000
2019-03-19	2019-03-15	4	CARPENTER CHRISTOPHER L.	RUBY	Stock Option (Right to Buy)	M - Exercise	D	2.87		-48,000		667,157
2019-03-19	2019-03-15	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	S - Sale	D		15.8357	-48,000	-760		34,843
2019-03-19	2019-03-15	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	M - Exercise	D		2.8700	48,000	138		82,843
2019-02-14	2018-11-28	5	Epstein David R By Three Opinions Foundation Inc.	RUBY	Common Stock	G - Gift	I			180,000			180,000
2019-02-14	2018-11-28	5	Epstein David R	RUBY	Common Stock	G - Gift	D			-180,000			4,800,453
2019-02-04	2019-01-31	4	CAGNONI PABLO J	RUBY	Stock Option (Right to Buy)	A - Award	D	13.69		100,000		100,000
2019-02-04	2019-01-31	4	NISSEN TORBEN STRAIGHT	RUBY	Stock Option (Right to Buy)	A - Award	D	13.69		175,000		175,000
2019-02-04	2019-01-31	4	CARPENTER CHRISTOPHER L.	RUBY	Stock Option (Right to Buy)	A - Award	D	13.69		100,000		100,000
2019-02-04	2019-01-31	4	OH ANDREW M.	RUBY	Stock Option (Right to Buy)	A - Award	D	13.69		115,000		115,000
2019-01-24	2019-01-22	4	CARPENTER CHRISTOPHER L.	RUBY	Stock Option (Right to Buy)	M - Exercise	D	2.87		-34,843		715,157
2019-01-24	2019-01-22	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	M - Exercise	D		2.8700	34,843	100		34,843
2019-01-18	2019-01-14	4	LANGER ROBERT	RUBY	Stock Option (Right to Buy)	M - Exercise	D	0.15		-7,500		142,500
2019-01-18	2019-01-14	4	LANGER ROBERT	RUBY	Common Stock	S - Sale	D		14.5925	-7,500	-109		0
2019-01-18	2019-01-14	4	LANGER ROBERT	RUBY	Common Stock	M - Exercise	D		0.1500	7,500	1		7,500
2018-11-01	2018-10-31	4	CAGNONI PABLO J	RUBY	Stock Option (Right to Buy)	A - Award	D	16.43		193,400		193,400
2018-11-01	2018-10-31	4	CAGNONI PABLO J	RUBY	Stock Option (Right to Buy)	A - Award	D	16.43		164,400		164,400
2018-07-23	2018-07-20	4	Symonds Jonathan	RUBY	Common Stock	P - Purchase	D		23.0000	25,000	575		25,000
2018-07-23	2018-07-20	4	Cuss Francis M	RUBY	Common Stock	P - Purchase	D		23.0000	10,000	230		10,000
2018-07-23	2018-07-20	4	Pomerantz Roger	RUBY	Common Stock	P - Purchase	D		23.0000	100	2		100
2018-07-23	2018-07-20	4	Sohn Catherine A.	RUBY	Common Stock	P - Purchase	D		23.0000	2,500	58		2,500
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Series C Preferred Stock	C - Conversion	I			-781,860		0
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Series C Preferred Stock	C - Conversion	I			-195,466		0
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Series C Preferred Stock	C - Conversion	I			-195,466		0
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Series B Preferred Stock	C - Conversion	I			-1,781,843		0
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Series B Preferred Stock	C - Conversion	I			-593,948		0
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Series B Preferred Stock	C - Conversion	I			-593,948		0
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Series A Preferred Stock	C - Conversion	I			-5,000,000		0
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Series A Preferred Stock	C - Conversion	I			-5,000,000		0
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Series A Preferred Stock	C - Conversion	I			-3,830,402		0
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Series A Preferred Stock	C - Conversion	I			-15,323,593		0
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	C - Conversion	I			781,860			2,563,703
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	C - Conversion	I			195,466			5,789,414
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	C - Conversion	I			195,466			5,789,414
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	C - Conversion	I			1,781,843			1,781,843
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	C - Conversion	I			593,948			5,593,948
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	C - Conversion	I			593,948			5,593,948
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	C - Conversion	I			5,000,000			5,000,000
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	C - Conversion	I			5,000,000			5,000,000
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	C - Conversion	I			3,830,402			3,830,402
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	C - Conversion	I			15,323,593			15,323,593
2018-07-18	2018-07-17	4	Symonds Jonathan	RUBY	Stock Option (Right to Buy)	A - Award	D	23.00		25,000		25,000
2018-07-18	2018-07-17	4	Cuss Francis M	RUBY	Stock Option (Right to Buy)	A - Award	D	23.00		25,000		25,000
2018-07-18	2018-07-17	4	Epstein David R	RUBY	Stock Option (Right to Buy)	A - Award	D	23.00		1,902,977		1,902,977
2018-07-18	2018-07-17	4	Sohn Catherine A.	RUBY	Stock Option (Right to Buy)	A - Award	D	23.00		25,000		25,000
2018-07-18	2018-07-17	4	Rosenblatt Michael	RUBY	Stock Option (Right to Buy)	A - Award	D	23.00		25,000		25,000
2018-07-18	2018-07-17	4	LANGER ROBERT	RUBY	Stock Option (Right to Buy)	A - Award	D	23.00		25,000		25,000
2018-07-18	2018-07-17	4	Pomerantz Roger	RUBY	Stock Option (Right to Buy)	A - Award	D	23.00		25,000		25,000
2018-07-18	2018-07-17	4	AFEYAN NOUBAR	RUBY	Stock Option (Right to Buy)	A - Award	D	23.00		25,000		25,000
2018-07-17		3	Epstein David R	RUBY	Common Stock		D						9,960,906
2018-07-17		3	Epstein David R	RUBY	Common Stock		D						9,960,906
2018-07-17		3	Epstein David R	RUBY	Common Stock		D						9,960,906
2018-07-17		3	NISSEN TORBEN STRAIGHT	RUBY	Common Stock		D						3,720,000
2018-07-17		3	NISSEN TORBEN STRAIGHT	RUBY	Common Stock		D						3,720,000
2018-07-17		3	NISSEN TORBEN STRAIGHT	RUBY	Common Stock		D						3,720,000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10,000,000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10,000,000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10,000,000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10,000,000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10,000,000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10,000,000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10,000,000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10,000,000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10,000,000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10,000,000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10,000,000

Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif

Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif

Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)

Penukaran derivatif

Penjualan atau pemindahan sekuriti kembali kepada syarikat

Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat

Hadiah sekuriti oleh atau kepada orang dalam

Swap ekuiti dan urus niaga lindung nilai yang serupa

Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)

Transaksi dilaporkan secara sukarela pada Borang 4

Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)

RUBY / Rubius Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5